{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T15:24:28Z","timestamp":1759073068272},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Afonso Paulo Padovan for expert technical assistance"},{"name":"Ruither de Oliveira Gomes Carolino and Dr"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.bbr.2016.08.024","type":"journal-article","created":{"date-parts":[[2016,8,15]],"date-time":"2016-08-15T07:45:55Z","timestamp":1471247155000},"page":"115-122","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Panic-modulating effects of alprazolam, moclobemide and sumatriptan in the rat elevated T-maze"],"prefix":"10.1016","volume":"315","author":[{"given":"Ana Beatriz","family":"Sant\u2019Ana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz Fernando","family":"Weffort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thatiane","family":"de Oliveira Sergio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael Calsoni","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alana Tercino","family":"Frias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melina","family":"Matthiesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heloisa Helena","family":"Vilela-Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula Shimene de Melo","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex Teles","family":"Vasconcelos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valquiria","family":"de Bortoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina Marta","family":"Del-Ben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Helio","family":"Zangrossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2016.08.024_bib0005","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2174\/1871524911006030207","article-title":"The dual role of serotonin in defense and the mode of action of antidepressants on generalized anxiety and panic disorders","volume":"10","author":"Graeff","year":"2010","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"key":"10.1016\/j.bbr.2016.08.024_bib0010","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0301-0082(03)00087-X","article-title":"The neurobiology and control of anxious states","volume":"70","author":"Millan","year":"2003","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bbr.2016.08.024_bib0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1385\/NMM:5:1:027","article-title":"The serotonergic system and anxiety","volume":"5","author":"Gordon","year":"2004","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.bbr.2016.08.024_bib0020","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1017\/S1461145704004870","article-title":"Evidence-based pharmacotherapy of generalized anxiety disorder","volume":"8","author":"Baldwin","year":"2005","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.bbr.2016.08.024_bib0025","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/026988119100500414","article-title":"5-HT and mechanisms of defence","volume":"5","author":"Deakin","year":"1991","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.bbr.2016.08.024_bib0030","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.neubiorev.2003.12.004","article-title":"Serotonin, the periaqueductal gray and panic","volume":"28","author":"Graeff","year":"2004","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbr.2016.08.024_bib0035","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0166-4328(93)90097-A","article-title":"Role of the amygdala and periaqueductal gray in anxiety and panic","volume":"58","author":"Graeff","year":"1993","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2016.08.024_bib0040","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0091-3057(94)90067-1","article-title":"The elevated T-maze: a new animal model of anxiety and memory","volume":"49","author":"Viana","year":"1994","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2016.08.024_bib0045","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.neubiorev.2014.03.007","article-title":"Serotonin in anxiety and panic: contributions of the elevated T-maze","volume":"46","author":"Zangrossi","year":"2014","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbr.2016.08.024_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00504983","article-title":"Effects of alpha-adrenoceptor agonists in a maze exploration model of \u2018fear\u2019-motivated behaviour","volume":"327","author":"Handley","year":"1984","journal-title":"Naunyn. Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.bbr.2016.08.024_bib0055","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0165-0270(85)90031-7","article-title":"Validation of open: closed arm entries in the elevated plus maze as a measure of anxiety in the rat","volume":"14","author":"Pellow","year":"1985","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.bbr.2016.08.024_bib0060","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0091-3057(93)90492-C","article-title":"Anxiogenic stimuli in the elevated plus-maze","volume":"44","author":"Treit","year":"1993","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2016.08.024_bib0065","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bbr.2014.07.024","article-title":"Influence of procedural variables on rat inhibitory avoidance and escape behaviors generated by the elevated T-maze","volume":"273","author":"Pobbe","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2016.08.024_bib0070","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0361-9230(01)00480-4","article-title":"Nitric oxide may underlie leadrned fear in the elevated T-maze","volume":"55","author":"Calixto","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.bbr.2016.08.024_bib0075","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0166-4328(03)00151-7","article-title":"Antipanic-like effect of serotonin reuptake inhibitors in the elevated T-maze","volume":"147","author":"Poltronieri","year":"2003","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2016.08.024_bib0080","doi-asserted-by":"crossref","first-page":"839","DOI":"10.4088\/JCP.10r06218blu","article-title":"The pharmacologic treatment of anxiety disorders: a review of progress","volume":"71","author":"Ravindran","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.bbr.2016.08.024_bib0085","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1017\/S1092852900016965","article-title":"Monoamine oxidase inhibitors: a modern guide to an unrequited class of antidepressants","volume":"13","author":"Stahl","year":"2008","journal-title":"CNS Spectr."},{"key":"10.1016\/j.bbr.2016.08.024_bib0090","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1468-2982.2004.00694.x","article-title":"Triptans and CNS side-effects: pharmacokinetic and metabolic mechanisms","volume":"24","author":"Dodick","year":"2004","journal-title":"Cephalalgia"},{"key":"10.1016\/j.bbr.2016.08.024_bib0095","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1177\/0269881112472560","article-title":"The 5-HT1D\/1B receptor agonist sumatriptan enhances fear of simulated speaking and reduces plasma levels of prolactina","volume":"27","author":"de Rezende","year":"2013","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.bbr.2016.08.024_bib0100","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.euroneuro.2004.12.002","article-title":"Anxiogenic effects of Sumatriptan in panic disorder: a double-blind placebo-controlled study","volume":"15","author":"Amital","year":"2005","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.bbr.2016.08.024_bib0105","doi-asserted-by":"crossref","first-page":"423","DOI":"10.31887\/DCNS.2011.13.4\/nkoen","article-title":"Pharmacotherapy of anxiety disorders: a critical review","volume":"13","author":"Koen","year":"2011","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.bbr.2016.08.024_bib0110","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/JCP.0b013e31822d0012","article-title":"The efficacy and safety of alprazolam versus other benzodiazepines in the treatment of panic disorder","volume":"31","author":"Moylan","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.bbr.2016.08.024_bib0115","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00213-008-1134-7","article-title":"Alprazolam potentiates the antiaversive effect induced by the activation of 5-HT(1A) and 5-HT(2A) receptors in the rat dorsal periaqueductal gray","volume":"198","author":"de Bortoli","year":"2008","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.bbr.2016.08.024_bib0120","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0166-4328(03)00151-7","article-title":"Antipanic-like effect of serotonina reuptake inhibitors in the elevated T-maze","volume":"147","author":"Poltronieri","year":"2003","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2016.08.024_bib0125","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0091-3057(99)00261-0","article-title":"Behavioral effects of acute and chronic imipramine in the elevated T-maze model of anxiety","volume":"65","author":"Teixeira","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2016.08.024_bib0130","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s002130050282","article-title":"Behavioural profiles of the reversible monoamine-oxidase-A inhibitors befloxatone and moclobemide in an experimental model for screening anxiolytic and anti-panic drugs","volume":"131","author":"Griebel","year":"1997","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.bbr.2016.08.024_bib0135","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/0014-2999(72)90204-X","article-title":"Long-term effects of p-chloroamphetamine on tryptophan hydroxylase activity and on the levels of 5-hydroxytriptamine and 5-hydroxyindole acetic acid in brain","volume":"20","author":"Sanders-Bush","year":"1972","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2016.08.024_bib0140","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00210-004-0939-0","article-title":"Antidepressant-like effects of the nociception\/orphanin FQ receptor antagonist UFP-101: new evidence from rats and mice","volume":"368","author":"Gravioli","year":"2004","journal-title":"Naunyn. Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.bbr.2016.08.024_bib0145","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.pbb.2013.05.013","article-title":"Effects of compounds that interfere with the endocannabinoid system on behaviors predictive of anxiolytic and panicolytic activities in the elevated T-maze","volume":"110","author":"Gobira","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2016.08.024_bib0150","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0014-2999(82)90421-6","article-title":"Interactions between serotonerfic and enkephalinergic neurons in rat striatum and hypothalamus","volume":"85","author":"Dellavedova","year":"1982","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2016.08.024_bib0155","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/cne.903130409","article-title":"A PHA-L analysis projections of the dorsal raphe nucleus in the rat","volume":"313","author":"Vertes","year":"1991","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.bbr.2016.08.024_bib0160","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0006-8993(76)91024-6","article-title":"Behavioral studies following lesions of the mesolimbic and mesostriatal serotoneric pathways","volume":"106","author":"Geyer","year":"1976","journal-title":"Brain Res."},{"key":"10.1016\/j.bbr.2016.08.024_bib0165","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1527-3458.2003.tb00245.x","article-title":"Moclobemide: therapeutic use and clinical studies","volume":"9","author":"Bonnet","year":"2003","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.bbr.2016.08.024_bib0170","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0161-813X(03)00097-4","article-title":"Clinical pharmacology of MAO inhibitors: safety and future","volume":"25","author":"Yamada","year":"2004","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.bbr.2016.08.024_bib0175","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0166-4328(03)00184-0","article-title":"Use of the elevated T-maze to study anxiety in mice","volume":"148","author":"Carvalho-Neto","year":"2004","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2016.08.024_bib0180","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0028-3908(98)00077-X","article-title":"Behavioral effects of phenelzine in an experimental model for screening anxiolytic and anti-panic drugs: correlation with changes in monoamine-oxidase activity and monoamine levels","volume":"37","author":"Griebel","year":"1998","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2016.08.024_bib0185","doi-asserted-by":"crossref","first-page":"485","DOI":"10.31887\/DCNS.2011.13.4\/mkellner","article-title":"Experimental panic provocation in healthy man\u2014a translational role panic drug development?","volume":"13","author":"Kellner","year":"2011","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.bbr.2016.08.024_bib0190","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2174\/1568026799078688","article-title":"Treatment strategies of obsessive-compulsive disorder and panic disorder\/agoraphobia","volume":"12","author":"Marazziti","year":"2012","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.bbr.2016.08.024_bib0195","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0165-1781(95)02673-K","article-title":"Dorsal periaqueductal gray-induced aversion as a simulation of panic anxiety: elements of face and predictive validity","volume":"57","author":"Jenck","year":"1995","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbr.2016.08.024_bib0200","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuropharm.2006.03.009","article-title":"Prediction of anti-panic properties of escitalopram in the dorsal periaqueductal grey model of panic anxiety","volume":"51","author":"Hogg","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2016.08.024_bib0205","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/0028-3908(95)00121-2","article-title":"Further evidence that the mouse defense test battery is useful for screening anxiolytic and panicolytic drugs: effects of acute and chronic treatment with alprazolam","volume":"34","author":"Griebel","year":"1995","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2016.08.024_bib0210","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0014-2999(01)00851-2","article-title":"Sedative and anxiolytic effects of zopiclone\u2019s enantiomers and metabolite","volume":"415","author":"Carlson","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2016.08.024_bib0215","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0306-3623(94)00148-G","article-title":"The modified light\/dark transition test in mice: evalutation of classic and putative anxiolytic and anxiogenic drugs","volume":"26","author":"Shimada","year":"1995","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.bbr.2016.08.024_bib0220","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1600-0447.1987.tb07747.x","article-title":"Pharmacology of the benzodiazepines: with special emphasis on alprazolam","volume":"335","author":"S\u00f6derpalm","year":"1987","journal-title":"Acta. Psychiatr. Scand. Suppl."},{"key":"10.1016\/j.bbr.2016.08.024_bib0225","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0028-3908(98)00115-4","article-title":"Axiolytic-like actions of BW 723C86 in the rat Vogel conflict test are 5-HT2B receptor mediated","volume":"37","author":"Kennett","year":"1998","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.bbr.2016.08.024_bib0230","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0091-3057(95)02126-4","article-title":"A review of the validity and variability of the elevated plus-maze as an animal model of anxiety","volume":"54","author":"Hogg","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2016.08.024_bib0235","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0091-3057(01)00746-8","article-title":"Molecular, pharmacological and functional diversity of 5-HT receptors","volume":"71","author":"Hoyer","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbr.2016.08.024_bib0240","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/j.1476-5381.1995.tb13321.x","article-title":"Evidence that 5-hydroxytriptamine release in rat dorsal raphe nucleus is controlled by 5-HT1A, 5-HT1B and 5-HT1D autoreceptors","volume":"115","author":"Davidson","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbr.2016.08.024_bib0245","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0165-6147(89)90159-4","article-title":"Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brainl","volume":"10","author":"Hoyer","year":"1989","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbr.2016.08.024_bib0250","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0014-2999(92)90142-Q","article-title":"The interaction of R(+)- and S(\u2212)-zacopride with p-CPA to modify rodent aversive behavior","volume":"218","author":"Barnes","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbr.2016.08.024_bib0255","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1476-5381.1991.tb12261.x","article-title":"Effect of p-chlorophenylalanine on release of 5-hydroxytryptamine from the rat frontal cortex in vivo","volume":"102","author":"O\u2019Connell","year":"1991","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbr.2016.08.024_bib0260","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1601-5215.2012.00669.x","article-title":"5-HT depletion, but not 5-HT1A antagonist, prevents the anxiolytic-like effect of citalopram in rat contextual conditioned fear stress model","volume":"2","author":"Matsudda","year":"2013","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.bbr.2016.08.024_bib0265","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0306-4522(00)00336-5","article-title":"Behavioral, neurochemical and endocrinological characterization of the early social isolation syndrome","volume":"100","author":"Heidbreder","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2016.08.024_bib0270","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.yhbeh.2012.05.011","article-title":"Effects of social isolation on glucocorticoid regulation in social mammals","volume":"3","author":"Hawkley","year":"2012","journal-title":"Horm. Behav."},{"key":"10.1016\/j.bbr.2016.08.024_bib0275","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.yebeh.2006.09.002","article-title":"Phenytoin normalizes exaggerated fear behavior in p-chlorophenylalanine (PCPA)-treated rats","volume":"4","author":"Hughes","year":"2006","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.bbr.2016.08.024_bib0280","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0028-3908(94)90076-0","article-title":"Evidence that mCPP-induced anxiety in the plus-maze is mediated by postsynaptic 5-HT2C receptors but not by sympathomimetic effects","volume":"33","author":"Gibson","year":"1994","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2016.08.024_bib0285","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF01578754","article-title":"Does the PCPA induced anticonflict effect involve activation of the GABAA\/benzodiazepine chloride ionophore receptor complex?","volume":"76","author":"S\u00f6derpalm","year":"1989","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.bbr.2016.08.024_bib0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ijnp\/pyv018","article-title":"Differences in anxiety-like behavior within a batch of wistar rats are associated with differences in serotonergic transmission, enhanced by acute administration, and abolished by serotonin depletion","volume":"18","author":"N\u00e4slund","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.bbr.2016.08.024_bib0295","first-page":"353","article-title":"Clonazepam for the treatment of panic-disorder","volume":"14","author":"Nardi","year":"2013","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.bbr.2016.08.024_bib0300","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11920-016-0668-3","article-title":"Long-term pharmacological treatments of anxiety disorders: an updated systematic review","volume":"18","author":"Perna","year":"2016","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.bbr.2016.08.024_bib0305","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bbr.2014.07.024","article-title":"Influence of procedural variables on rat inhibitory avoidance and escape behaviors generated by the elevated T-maze","volume":"273","author":"Pobbe","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bbr.2016.08.024_bib0310","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/j.peptides.2004.06.016","article-title":"Systemic and intra-dorsal periaqueductal gray injections of cholecystokinin sulfated octapeptide (CCK-8s) induce a panic-like response in rats submitted to the elevated T-maze","volume":"25","author":"Zanoveli","year":"2004","journal-title":"Peptides"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432816305368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432816305368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T23:50:41Z","timestamp":1657065041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432816305368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":62,"alternative-id":["S0166432816305368"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2016.08.024","relation":{},"ISSN":["0166-4328"],"issn-type":[{"type":"print","value":"0166-4328"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Panic-modulating effects of alprazolam, moclobemide and sumatriptan in the rat elevated T-maze","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2016.08.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}